Study Requirements

You may qualify if you:

have histologically or cytologically confirmed diagnosis of non-squamous NSCLC
Locally advanced or metastatic disease.
Evidence of KRAS G12C mutation via tumor sample and/or ctDNA documented by
Sponsor-approved laboratory testing

Potential Benefits of Participation

Maginfying

Access to new treatments that are not yet available to the general public.

Hand Heart

Personalized medical attention from leading healthcare professionals.

Helios

Compensation provided to qualified participants

Study Locations

These studies are currently enrolling at the following sites:

The Oncology Institute of Hope Powered by Helios - Fountain Valley, CA
The Oncology Institute of Hope Powered by Helios - Whittier, CA
The Oncology Institute of Hope Powered by Helios - Long Beach, CA

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.